Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000177042 | SCV000228854 | benign | not specified | 2015-05-13 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000177042 | SCV000269758 | benign | not specified | 2015-01-13 | criteria provided, single submitter | clinical testing | p.Ile75Val in exon 3 of RPGR: This variant is not expected to have clinical sign ificance because it has been identified in 8.9% (343/3833) of African American c hromosomes from a broad population by the NHLBI Exome Sequencing Project (http:/ /evs.gs.washington.edu/EVS; dbSNP rs111631988). |
Labcorp Genetics |
RCV000474670 | SCV000557300 | benign | Primary ciliary dyskinesia | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000086937 | SCV001950986 | benign | not provided | 2018-07-09 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 22995991, 22025579, 9399904, 27884173) |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000177042 | SCV002074202 | likely benign | not specified | 2022-01-11 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000474670 | SCV002727944 | benign | Primary ciliary dyskinesia | 2014-12-01 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV000086937 | SCV002759503 | benign | not provided | 2019-11-27 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002498471 | SCV002808043 | benign | X-linked cone-rod dystrophy 1; Retinitis pigmentosa 3; Retinitis pigmentosa, X-linked, and sinorespiratory infections, with or without deafness; Macular degeneration, X-linked atrophic | 2021-11-09 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000086937 | SCV005209240 | likely benign | not provided | criteria provided, single submitter | not provided | ||
NEI Ophthalmic Genomics Laboratory, |
RCV000086937 | SCV000119189 | not provided | not provided | no assertion provided | not provided | ||
Department of Ophthalmology and Visual Sciences Kyoto University | RCV000086937 | SCV000172560 | probable-non-pathogenic | not provided | no assertion criteria provided | not provided | Converted during submission to Likely benign. |